Pharmacist Alzheimer's / Dementia Podcast 30m

Recent preclinical studies highlight the potential of micro-dosed lithium to modulate Alzheimer’s disease pathology and support neuronal health. This episode examines the molecular mechanisms, current evidence in Alzheimer’s models, and emerging considerations for safe use and monitoring. You will gain insights to navigate this evolving topic and support informed discussions around lithium micro-dosing in Alzheimer’s care.

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Describe current evidence on the use of microdose lithium in Alzheimer’s disease.
2. Identify pharmacist considerations for monitoring, patient selection, and safety in the context of lithium micro-dosing for Alzheimer’s.

Faculty

Rachel Maynard, PharmD

GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Disclosures:

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

Dawn Gerber, PharmD, BCGP, FASCP, FAzPA, CPAFH

Professor of Pharmacy Practice
Midwestern University

Disclosures:

Dawn Gerber has no relevant financial relationships with ineligible companies to disclose.

Course Details